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Abstract 
Purpose: To investigate the inhibitory effects of various ratios of polysaccharides/ alkaloids from the 
rhizome of Coptis chinensis Franch (RCC) on α-glucosidase. 
Methods: The polysaccharides (PSD) and alkaloids (ALK) from RCC were prepared using the water 
extraction and alcohol precipitation method and Reinecke’s salt precipitation method, respectively. 
Subsequently, the α-glucosidase inhibitory effects of PSD, ALK, and PSD/ALK at various ratios were 
evaluated spectrophotometrically in vitro.  
Results: With a half maximal inhibitory concentration (IC50) value of 171.67 μg/mL,  ALK showed higher 
α-glucosidase inhibitory activity than PSD (IC50 = 296.89 μg/mL). In addition, the 
polysaccharides/alkaloids (PSD/ALK) at the ratio of 3:1 exhibited stronger α-glucosidase inhibitory 
activity (IC50 = 160.9 μg/mL) than PSD, ALK and PSD/ALK at ratios of 1:3 (IC50 = 394.78 μg/mL), 1:2 
(IC50 = 185.18 μg/mL), 1:1 (IC50 = 350.51 μg/mL), and 2:1 (IC50 = 229.16 μg/mL). 
Conclusion: The results obtained suggest that PSD/ALK (3:1) possesses the strongest α-glucosidase 
inhibitory effect and may be considered as a candidate agent in future anti-diabetes drug development.  
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The dried rhizome of Coptis chinensis Franch 
(RCC) (Ranunculaceae family) is one of the most 
widely used traditional Chinese medicines 
(TCMs) in China [1,2]. It has been used for 
thousands of years in Chinese traditional 
medicine to treat damp-heat, dysentery, 
jaundice, heart fire hyperactivity, carbuncles and 
sores [2]. Increasingly modern pharmacological 
investigations have demonstrated that the 
extracts/compounds isolated from RCC can be 
used to treat inflammation [3], infection [4], 
dysentery [5], hypertension [6], gastrointestinal 
cancer [7], and type 2 diabetes mellitus (T2DM) 
[8]. In addition, recent research has also reported 
that RCC contains various chemical constituents 
including alkaloids, polysaccharides, and organic 
acids [8-11].  
 
In recent years, morbidity from diabetes mellitus 
(DM) has increased dramatically, and DM has 
become one of modern medicine’s most 
intractable diseases [12]. Importantly, T2DM 
makes up approximately 90 % of DM cases [13]. 
Although insulin and other first-line drugs for 
treating T2DM have been widely used in clinics, 
some drugs involve significant adverse effects 
(e.g., abdominal distention, diarrhea, and 
flatulence) that limit their clinical popularity [8,14]. 
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Therefore, it is important to discover more novel 
drugs for treating T2DM. Previous studies have 
demonstrated that RCC possesses a notable 
anti-diabetic effect, and alkaloids were reported 
to be its primary bioactive constituents [8,15]. 
Moreover, a water-soluble polysaccharide 
isolated from C. chinensis has been proven to 
possess significant antidiabetic and antioxidant 
activity [16]. However, no investigations of the 
antidiabetic-like effect of these two types of 
active ingredients (i.e., polysaccharides and 
alkaloids) used in combination have been 
reported. Therefore, in this study, we aim to 
investigate the inhibitory effects of 
polysaccharides, alkaloids, and in particular 
various ratios of polysaccharides/alkaloids from 
the rhizome of C. chinensis on α-glucosidase. 
The present study lays a solid foundation for the 
development and utilization of C. chinensis. More 
importantly, these results will provide information 
for the future development of candidate drugs for 






Coptis chinensis Franch was collected from Dayi 
County (Chengdu, China) and identified by 
Professor Yi Zhang (Chengdu University of 
Traditional Chinese Medicine), and a voucher 
specimen was deposited in the herbarium of the 
College of Ethnic Medicine, Chengdu University 





Acarbose was purchased from Chengdu 
Herbpurity Co., Ltd. (Chengdu, China), and its 
purity was ≥ 98 %; α-glucosidase and 4-
nitrobenzene-α-D-glucopyranoside (PNPG) were 
purchased from Sigma Co. (St., Louis, MO, 
USA); p-nitrophenol (PNP) was purchased from 
Chengdu Kelong Chemical Reagent Co. Ltd. 
(Chengdu, China). All of the other reagents used 
in the present study were of analytical grade.  
 
Preparation of polysaccharides and alkaloids 
from the rhizome of Coptis chinensis 
 
The polysaccharides (PSD) and alkaloids (ALK) 
from the rhizome of Coptis chinensis were 
prepared as shown in the flow chart in Figure 1. 
The RCC was powdered and refluxed with water 
three times (4 h each time). Subsequently, 
ethanol (EtOH) was added slowly until a final 
concentration of 80 % was obtained. After being 
left overnight at 4 °C, the precipitates were 
collected by filtering and being washed three 
times with pure ethanol and acetone, and the 
precipitate (crude polysaccharides) (A) and 
supernatant (B) were collected. The crude 
polysaccharides were deproteinized using 
CHCl3-butanol (v/v, 5:1), then the refined 
polysaccharides were obtained by freeze-drying.  
 
The supernatant (B) was concentrated in vacuum 
and diluted H2SO4 was added to adjust the pH 
value to 2–3. Subsequently, the freshly prepared 
Reinecke’s salt was added to the supernatant 
and the precipitate (D) and the supernatant (C) 
were collected, respectively. The precipitate (D) 
was later redissolved in acetone, then underwent 
Al2O3 column chromatography and eluted with 
acetone. Next, the elutriant was collected and 
silver sulfate solution (Ag2SO4) was added. 
Thereafter, the supernatant was collected and 
freeze-dried to obtain the total alkaloids. In 
addition, the supernatant (C) from the previous 





Figure 1: Flow chart of preparation of polysaccharides 
(PSD), alkaloids (ALK) and the residues (RES) from 
the rhizome of Coptis chinensis 
 
Inhibition of α-glucosidase by extract 
 
The α-glucosidase inhibitory activity assay was 
performed according to the previously described 
method [17] with minor modifications. The assay 
system was performed in 96-well plates in a total 
volume of 250 µL. The reaction mixture 
consisted of crude enzyme solution (0.2 
units/mL, 10 μL), 0.1 M potassium phosphate 
buffer (100 μL), and 50 μL test samples in DMSO 
at series final concentrations in the assay system 
(500, 375, 250, 187.5, 125 and 62.5 µg/mL). 
Acarbose (ACB, 500, 375, 250, 187.5, 125 and 
62.5 µg/mL) was used as positive control. After 
pre-incubation at 37 °C for 15 min, 20 μL of 2.5 
mM PNPG was added. The mixture was 
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incubated for another 15 min at 37 °C. The 
reaction was terminated by adding 70 μL of 0.2 
M Na2CO3. The absorbance (Abs) was then 
measured at 405 nm using a microplate reader 
(Thermo, USA). Individual blanks for test 
samples were prepared to correct background 
absorbance where the substrate was replaced 
with buffer. Control sample contained 50 μL 
DMSO instead of test samples. Thereafter, α-
glucosidase inhibitory activity was calculated 
according to Eq 1. 
 
Inhibition (%) = {(Ac – As)/Ac} …………….. (1)  
 
where Ac and As are the absorbance of of 
control and test samples, respectively. 
 
Finally, the half maximal inhibitory concentration 
(IC50) value was calculated using SPSS software 





Inhibitory effect of sub-fractions of Coptis 
chinensis on α-glucosidase 
 
As shown in Table 1, the positive reference 
(Acarbose) exhibited a significant inhibitory effect 
on α-glucosidase with IC50 value of 183.15 
μg/mL. For PSD and ALK test samples isolated 
from RCC, a serial concentration (500, 375, 250, 
187.5, 125, and 62.5 µg/mL) was determined. 
The results of demonstrated that both PSD and 
ALK possess significant α-glucosidase inhibitory 
effects, with IC50 of 296.89 and 171.67 μg/mL, 
respectively. Importantly, ALK showed a stronger 
α-glucosidase inhibitory effect than the positive 
drug (Acarbose) (171.67 and 183.15 μg/mL, 
respectively). However, the test samples of the 
RES had a weak effect on the α-glucosidase, 
with an IC50 value of over 500 μg/mL. 
Considering its weak α-glucosidase inhibitory 
effect and low yield, RES was not used in the 
subsequent experiment. 
 
Inhibitory effect of various ratios of PSD/ALK 
on α-glucosidase 
 
In order to obtain the best α-glucosidase 
inhibitory effect, the various ratios of PSD/ALK 
were investigated. In our study, the testing ratios 
of PSD/ALK were set at 1:3, 1:2, 1:1, 2:1, and 
3:1. As seen in the results shown in Table 2, the 
IC50 of these samples were 394.78, 185.18, 
350.51, 229.16, and 160.9 μg/mL, respectively. 
Of these ratios, 3:1 showed the strongest α-
glucosidase inhibitory effect, which is even 
stronger than the positive reference agent 
(Acarbose) (160.9 vs. 183.15 μg/mL) (Figure 2). 
 
 
  Table 1: Inhibitory effect of sub-fractions of Coptis chinensis on α-glucosidase 
 

































Key: ACB, Acarbose; PSD, Polysaccharides; ALK, Alkaloids; RES, the residues; nd means 
that no inhibitory effect is detected 
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Table 2: Inhibitory effects of different ratios of polysaccharides/alkaloids on α-glucosidase 
 









































Key: PSD, Polysaccharides; ALK, Alkaloids.  
 
 
Figure 2: Inhibitory effect of polysaccharides, alkaloids and different ratios of polysaccharides/alkaloids on α-




Increasingly, investigations have indicated that 
natural monomers/extracts isolated from plants 
or herbs are a potential resource for developing 
novel effective candidate drugs with low toxicity 
[17-19]. Here we have presented, to the best of 
our knowledge, the first report on the optimum 
ratio of polysaccharides and alkaloids (3:1) 
isolated from the rhizome of Coptis chinensis for 
inhibiting α-glucosidase. 
 
It has been demonstrated that controlling blood 
postprandial glucose levels is an important 
strategy for treating DM, especially T2DM 
[20,21].α-glucosidase is one of the most 
important enzymes for the hydrolysis of α-
glucosidic bonds in carbohydrates in order to 
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liberate absorbable glucose [20]. Therefore, α-
glucosidase inhibitors are effective drugs in 
treating T2DM. Acarbose, a microbial 
carbohydrate, is currently used in clinical practice 
as an α-glucosidase inhibitor for attenuating 
T2DM [22]. Thus, we selected acarbose as a 
positive reference drug in this study. The α-
glucosidase inhibitory activity assay is commonly 
used for rapid in vitro screening of potential anti-
diabetes drugs [19,20,23].  
 
It is well known that the synergistic effect of 
multi-components is one of the most important 
features of traditional Chinese medicine [24]. In 
this study, the PSD/ALK at the ratio of 3:1 were 
found to have a stronger α-glucosidase inhibitory 
activity (IC50 = 160.9 μg/mL) than either the PSD 
or the ALK alone, indicating that the combined 
use of PSD and ALK can achieve a better 
inhibitory effect on α-glucosidase than using ALK 




This investigation has shown that the combined 
use of polysaccharides and alkaloids from the 
rhizome of Coptis chinensis at a ratio of 3:1 
produced the strongest α-glucosidase inhibitory 
effect. This combination may be considered as a 
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